Quest Diagnostics Incorporated DGX
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 11.84B | 11.56B | 11.28B | 11.04B | 10.85B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 11.84B | 11.56B | 11.28B | 11.04B | 10.85B |
| Cost of Revenue | 7.91B | 7.72B | 7.52B | 7.36B | 7.22B |
| Gross Profit | 3.93B | 3.84B | 3.75B | 3.68B | 3.63B |
| SG&A Expenses | 2.03B | 2.01B | 1.96B | 1.93B | 1.90B |
| Depreciation & Amortization | 149.00M | 151.00M | 152.00M | 154.00M | 154.00M |
| Other Operating Expenses | -3.00M | -1.00M | -3.00M | -1.00M | 1.00M |
| Total Operating Expenses | 10.09B | 9.88B | 9.63B | 9.44B | 9.27B |
| Operating Income | 1.75B | 1.68B | 1.64B | 1.60B | 1.58B |
| Income Before Tax | 1.52B | 1.43B | 1.40B | 1.36B | 1.33B |
| Income Tax Expenses | 342.00M | 320.00M | 329.00M | 314.00M | 301.00M |
| Earnings from Continuing Operations | 1.18K | 1.11K | 1.08K | 1.05K | 1.03K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -51.00M | -51.00M | -51.00M | -54.00M | -57.00M |
| Net Income | 1.13B | 1.06B | 1.02B | 992.00M | 969.00M |
| EBIT | 1.75B | 1.68B | 1.64B | 1.60B | 1.58B |
| EBITDA | 2.34B | 2.26B | 2.22B | 2.17B | 2.14B |
| EPS Basic | 10.18 | 9.53 | 9.17 | 8.86 | 8.63 |
| Normalized Basic EPS | 8.32 | 7.90 | 7.62 | 7.38 | 7.17 |
| EPS Diluted | 10.06 | 9.44 | 9.07 | 8.77 | 8.55 |
| Normalized Diluted EPS | 8.21 | 7.81 | 7.54 | 7.30 | 7.08 |
| Average Basic Shares Outstanding | 442.00M | 444.00M | 445.00M | 446.00M | 446.00M |
| Average Diluted Shares Outstanding | 448.00M | 449.00M | 450.00M | 451.00M | 452.00M |
| Dividend Per Share | 3.38 | 3.32 | 3.26 | 3.20 | 3.15 |
| Payout Ratio | 32.68% | 34.18% | 34.86% | 35.58% | 35.81% |